GeneTiger, Austin, Texas, United States
Diagnostic technologies for identification of SARS-CoV-2 from human nasal, buccal, or saliva samples
Tech Brief: GeneTiger is an easy-to-use genetic testing device that can detect SARS-COV-2 in human saliva.
Early-stage Startup (Seed)
FIGURES OF MERIT Value Proposition: GeneTiger is at the intersection of assay development and diagnostic point-of-care applications. Our collaborations with researchers, medical schools, and private companies have been focused on bringing new assays to market in GeneTiger’s microfluidic consumable. Already, GeneTiger is accelerating diagnostic development by ensuring that assay protocols are identical in lab and clinical settings. We anticipate design improvements over the next few years; long-term, GeneTiger is intended to be a consumer-grade diagnostic device that can be used for at-home prophylactic testing. For our current clients, GeneTiger offers tailored assay development with immediate applications in near-patient settings. Remote software updates allow for custom features (such as online data access) to be quickly accessible to customers. At an extremely competitive price point, GeneTiger will transform diagnostic innovation for a modern era.